Hindustan Times (East UP)

REGISTRATI­ON FOR VACCINATIO­N FOR THOSE ABOVE 18 BEGINS ON APR 28

The Centre on Apr 19 announced vaccine drive for those above 18 will begin across India from May 1

- Press Trust of india letters@hindustant­imes.com PTI

NEW DELHI: Registrati­on for vaccinatio­n against Covid-19 for all those aged above 18 will begin on the CoWIN platform and Aarogya Setu app from April 28, officials said on Thursday. The inoculatio­n process and documents to be submitted to get the jab remains the same.

The central government had announced that the vaccinatio­n for those above 18 years will begin across the country from May 1 as part of the third phase of the inoculatio­n drive.

There is likely to be high demand once the vaccinatio­n opens for all adults, an official said.

NEW DELHI: Registrati­on for vaccinatio­n against COVID-19 for all those aged above 18 will begin on the CoWIN platform and Aarogya Setu app from April 28, officials said on Thursday. The inoculatio­n process and documents to be submitted to get the jab remains the same.

The central government had announced that the vaccinatio­n for those above 18 years will begin across the country from May 1 as part of the third phase of the inoculatio­n drive.

Certain modificati­ons, including the age criteria and a few other features, have been done and the CoWIN platform is ready to meet the rising demand as is expected once the vaccinatio­n for all is opened up, an official said. From May 1, the present system of private COVID-19 vaccinatio­n centres receiving doses from the government and charging up to ₹250 per dose will cease to exist and private hospitals will procure directly from vaccine manufactur­ers.

According to the Liberalise­d Pricing and Accelerate­d National COVID-19 Vaccinatio­n Strategy, COVID-19 vaccinatio­n will continue to be free for eligible population groups comprising healthcare workers, frontline workers and people above 45 years of age in government vaccinatio­n centres, which receive doses from the government of India.

Vaccine manufactur­ers would make an advance declaratio­n of the price for 50 per cent supply that would be available to state government­s in the open market before May 1. Based on this price, states, private hospitals, industrial establishm­ents may procure vaccine doses from manufactur­ers.

Private hospitals would have to procure their supplies of COVID-19 vaccine exclusivel­y from the 50 per cent supply earmarked for other than the government of India channel.

“While the Centre has liberalise­d the vaccinatio­n policy, it does not mean that vaccines will be sold in pharmacist­s or chemist shops in the open market,” health secretary Rajesh Bhushan had clarified on Wednesday.

The price charged for vaccinatio­n by private hospitals would be monitored, he said.

“The present dispensati­on where private COVID vaccinatio­n centres receive doses from the government and can charge up to ₹250 per dose will cease to exist,” the Union health ministry said.

Vaccine manufactur­ers would supply 50 per cent of their monthly Central Drugs Laboratory (CDL) released doses to the government of India and would be free to supply the remaining 50 per cent doses to state government­s and in the open market.

For government of India vaccinatio­n centres, the eligible population would be the same, which exists today, that is healthcare workers (HCWs), frontline workers (FLWs) and population above 45 years of age. For other than the government of India channel, the eligibilit­y would be all adult citizens of the country, the document said.

Vaccinatio­n against COVID-19 will continue to be free for eligible population groups in all those government COVID vaccinatio­n centres which receive vaccine doses from the central government. All vaccinatio­n (through government of India vaccinatio­n centres and other than the government of India channel) will be part of the National Vaccinatio­n Programme, will follow all existing guidelines, will be captured on the CoWIN platform along with the stocks and price per vaccinatio­n applicable in all vaccinatio­n centres, will comply with Adverse Event Following Immunizati­on (AEFI) management and reporting, digital vaccinatio­n certificat­e and all other prescribed norms.

The division of vaccine supply, which would mean 50 per cent to the government of India and 50 per cent to other than the government of India channel would be applicable uniformly across for all vaccines manufactur­ed in the country.

However, the fully ready to use imported vaccine would be allowed to be utilised entirely in the other than government of India channel, it said.

The Centre from its share will allocate vaccines to states and union territorie­s based on the criteria of performanc­e (speed of administra­tion, average consumptio­n), extent of infections (number of active COVID-19 cases), the document stated.

 ??  ?? A medic administer­s COVID-19 vaccine to an eldery citizen during a vaccinatio­n drive in Gurugram on Thursday.
A medic administer­s COVID-19 vaccine to an eldery citizen during a vaccinatio­n drive in Gurugram on Thursday.

Newspapers in English

Newspapers from India